ENTITY
CStone Pharmaceuticals

CStone Pharmaceuticals (2616 HK)

130
Analysis
Health Care • China
CStone Pharmaceuticals is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines for cancer patients. It has launched multiple innovative drugs, including sugemalimab, avapritinib, and pralsetinib, to address unmet medical needs in China and globally. The company was founded in 2015 and is headquartered in Suzhou, China.
more
Company Event • 25 Mar 2027 09:30 • Upcoming
Add To Calendar

H2 2026

Company Event • 27 Aug 2026 19:30 • Upcoming
Add To Calendar

H1 2026

Company Event • 26 Mar 2026 09:30 • Upcoming
Add To Calendar

H2 2025

Company Event • 20 Oct 2025 21:00 • Latest

Study update

Company Event • 14 Aug 2025 15:30 • Upcoming
Add To Calendar

H1 2025

x